Poway, CA, United States of America

Naishu Wang

This inventor holds 21 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Diagnostic Testing Technology. Top assignees: Dnt Scientific Research, LLC, Alfa Scientific Designs, Inc., Alfa Scientific Design, Inc.. Active years: 2003-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naishu Wang. Retrieved from https://idiyas.com/inventor/naishu-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 66.7


Average Co-Inventor Count = 1.9

ph-index = 6

Forward Citations = 135(Granted Patents)


Location History:

  • San Diego, CA (US) (2003 - 2018)
  • Poway, CA (US) (2006 - 2019)

Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Diagnostic Test
Driven Flow Technology
Immunological Testing
Specimen Collection
Progressive Compression
Analyte Detection
Chromatographic Testing
Rapid Testing
Sampling Method
Test Reader
Specimen Cup
Testing Apparatus
21 patents (USPTO):Explore Patents

Title: Innovations in Rapid Diagnostics: The Contributions of Naishu Wang

Introduction

Naishu Wang, based in Poway, California, is a prolific inventor known for his significant contributions to the field of rapid diagnostic testing. With 21 patents to his name, Wang has been instrumental in developing innovative devices that enhance the speed and efficiency of diagnostic procedures.

Latest Patents

Wang's recent patents include a novel rapid diagnostic test device and sampling method that employs driven flow technology. This progressive compression-driven flow cartridge is designed for liquid analysis and incorporates convenient sampling methods for various applications. The one-step device allows for direct sample collection using a sample pad attached to the cartridge, which not only delivers samples to test strips but also preserves a portion for laboratory confirmation. Notably, in cases where the biological sample is sourced from within the human body, such as the nose or throat, Wang's two-step device cleverly integrates a long-arm swab applicator and a specialized chamber for dissolving biological substances. This designed approach enables faster qualitative analyses compared to traditional diagnostic tools.

Furthermore, another patent focuses on simplifying the design of rapid diagnostic devices using the same driven flow technology. This test device reduces interpretation time to under one minute and cuts manufacturing costs significantly. By decreasing the distance between the housing opening and the conjugate pad, the device offers users a streamlined experience without the need for additional components to activate the sampling process.

Career Highlights

Wang’s career has involved meaningful contributions to companies such as DNT Scientific Research LLC and Alfa Scientific Designs, Inc. His expertise in rapid diagnostics has been vital in advancing technology that meets the needs of healthcare professionals and patients alike.

Collaborations

Throughout his career, Wang has collaborated with esteemed colleagues, including David F. Zhou and Michael Chang Chien. These partnerships have led to innovative advancements in diagnostic technologies, showcasing the importance of teamwork in driving invention and innovation.

Conclusion

Naishu Wang's innovations in rapid diagnostic testing reflect a commitment to improving health outcomes through technology. His impressive portfolio of patents not only highlights his inventive spirit but also his dedication to enhancing the effectiveness of diagnostic procedures. As research continues to evolve, Wang’s contributions will undoubtedly play a pivotal role in the future of rapid diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…